Drugs / GSK2036874A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01106092 | May → Sep 2010 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, poliomyelitis +1 | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK2036874A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01106092 ↗ |
| Modality | Vaccine | “GSK2036874A vaccine” NCT01106092 ↗ |